AbbVie Ready To Leverage Migraine Franchise In Crowded Market

Qulipta Adds Indication Not Covered By Botox, Ubrelvy

 
• By Mandy Jackson
  
Woman suffers migraine while standing in a crowd of people
AbbVie brings seventh CGRP inhibitor to crowded migraine market • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip